Outbreaks of norovirus (NoV) gastroenteritis are often associated with the consumption of contaminated bivalves such as oysters, clams, and mussels. Crassostrea virginica oysters trap the Norwalk virus through the intestinal type A-like histoblood group antigen (HBGA), a possible mechanism of bioaccumulation responsible for NoV outbreaks. In this study, we tested binding and inhibition of binding in three species of oysters and one species each of clams and mussels with NoVs, representing four HBGA receptor-binding patterns. Our results indicated that all three oyster species expressed type A-and type O-like HBGA in their gastrointestinal tissue. Similar type A-like antigens also were found in mussels and clams, but only some of them express the O-like antigens. Both genogroups I and 11 recombinant norovirus-like particles (rNoVLPs) bound to gastrointestinal homogenates from oysters, mussels, and clams, and the binding was inhibited by preincubation of the rNoVLP with HBGA-specific monoclonal antibodies or with types A or 0 HBGA-positive human saliva. Co-localization of rNoVLPs and HBGA on gastrointestinal epithelial cells of oysters, mussels, and clams was also observed by immunofluorescent microscopy. Finally, the binding of rNoVLP to oyster gastrointestinal homogenates was inhibited by incubation with HBGA analogs. This study significantly expands our understanding that multiple HBGAs are expressed in oyster, mussel, and clam gastrointestinal tissues, which could be the major mechanism of bioaccumulation of NoVs by these bivalves. Our results also suggest that this bioaccumulation could be reversed by incubation with HBGA analogs, a possible important new strategy for depuration.
It has been estimated that human noroviruses (NoV) cause 23 million cases of gastrointestinal disease in the United States annually, accounting for 50 to 67% of all foodborne illness (5, 8) . Outbreaks of NoV gastroenteritis are often associated with the consumption of oysters contaminated with NoV. Cheng et al. (4) reported that 53 (10.5%) of 507 oyster samples from I I countries were contaminated with potentially infectious NoV, based on the detection of NoV RNA by reverse transcription PCR. However, NoV-related illness is also associated with the consumption of other undercooked or raw bivalves, such as mussels and clams. Myrmel et al. (16) reported that the NoV detection rate in mussels varied seasonally from 0% (in summer) to 9.5% (in winter); 6.8% of 681 mixed samples of 9,000 individual mussels tested contained NoV. Outbreaks of NoV have also been linked to consumption of mussels harvested in southern Italy, and NoV have been detected in mussels from Britain, Germany, and Ireland (3) . NoV can also be concentrated in clams after bioaccumula tion and subsequent depuration (17, 18) . Kingsley et al. (13) reported detection of both hepatitis A and NoV in imPorted clams associated with foodbome illness. Morse et al. (15) reported that among 1,017 NoV-associated gastro-A uthor for correspondence. Tel: 510-559-5637; Fax: 510-559-5948: E-r nail: ptian@pw.usda.gov . enteritis cases, 813 (80%) cases were related to eating clams and 204 (20%) to eating oysters.
It has been hypothesized that bivalves concentrate viral particles during their feeding process. This occurs because bivalves obtain their food by a filter-feeding process that permits them to ingest small particles of organic matter selectively sieved from large volumes of water. The exact mechanism of NoV accumulation has not yet been characterized, but it is hypothesized that viral particles may accumulate by mechanical entrapment, direct chemical bonding, Van der Waals bonding, H-ion bonding, or other ionic bonding (6) . It was reported previously that poliovirus can attach to oysters via carbohydrate moieties present in the oyster (6) .
The involvement of carbohydrate moieties in NoV binding to human gastrointestinal cells has been well documented. The histo-blood group antigen (HBGA) on human cells function as receptors for both genogroup I (GI) and genogroup 11 (GII) human NoVs and recombinant viral-like particles (rNoVLP) (11) . Recently, we reported that HBGA are present in gastrointestinal homogenates from virginica oysters, and that HBGA binding co-localizes with the binding of GI rNW on gastrointestinal cells of virginica oysters (20) . We report here that the gastrointestinal cells from other oyster species and other bivalves (mussels and clams) also contain type A-like HBGA that co-localize with rNoVLP, binding on gastrointestinal cells of these bivalves. Cells and rNoVLP. Insect Sf9 cells were grown in Sf-900 11 SFM medium (Invitrogen, Carlsbad, Calif.) containing 1% anfibiotic/antimycotic (Invitrogen). rNoVLPs representing four distinct strain-specific patterns were constructed (9) . Recombinant baculovirus expressing capsid proteins of Norwalk-like virus particles (rNW), a prototype of GI NoV (8FIla, M87661), MOH (AF397156), VA207 (AY038599), and VA387 (AY038600) were constructed by using the Bac-to-Bac recombinant baculovir-us expression system (Invitrogen) (9, 12, 21) . rNoVLVs were purified from Sf9 insect cells infected with recombinant baculovirus as described previously (12) . Live Manila clams (Venerupisjaponica) and blue mussels (Mytilis edulis) were obtained from local seafood markets. Each bivalve was shucked and dissected to obtain bivalve stomach and digestive tissue (BSDT). One gram of BSDT was homogenized in 10 ml of phosphate-buffered saline (PBS^ pH 7.4) with an Omni TissueMaster homogenizer (Omni International, Marietta, Ga.).
MATERIALS AND METHODS

Reagents
Homogenized samples were then centrifuged at 3,000 X g for 15 min at 4'C. The supernatants were saved for detection and characterization of HBGA and binding of rNoVLP to BSDT Other BSDT samples were fixed overnight at room temperature in 10% PBS-buffered formalin and stored in 70% alcohol until processing. 3,000 in PBS was added to appropriate wells, and the wells were incubated at 37'C for I h, followed by three washes with 250 lul of TBS-T The presence of bound AP-conjugated goat anti-mouse antibody was detected by adding 100 jLl of p-nitrophenyl phosphate, disodium salt substrate at a concentration of I mg/ml in diethanolamine substrate buffer (Pierce, Rockford, 111.). The absorbance was read at 405 urn on a Spectramax ELISA reader (Molecular Devices, Sunnyvale, Calif.). rNoVLP binding assay and inhibition/competition assay.
A human saliva-based rNoVLP binding assay was modified to determine the inhibition/competition of rNoVLP binding to HBGA as described previously (9) . Briefly, Nunc-Immune plates were incubated at 4'C overnight with 100 lil of 1:4 PBS-diluted BSDT supernatant from individual bivalve or pooled bivalve samples. After the plate was washed twice with PBS, it was blocked with 300 KI of 10% skim milk, then rNoVLPs (I ng ml-1 ) or other rNoVLPs were added to each well, and the wells were incubated at 37'C for I h. To test the role of carbohydrate in rNoVLP binding, wells were treated with 0.5% potassium periodate to oxidize carbohydrate prior to the addition of rNoVLP For inhibition assays, 900 lal of rNoVLPs (I ng ml-1 ) were preincubated for 30 min at 35'C, with either 10 lil of PBS (no inhibitor control) or 10 KI of candidate inhibitors (MAb or saliva samples), and 100 ^Ll was added to the microtiter wells. After a I-h incubation at 37'C, unbound rNoVLPs were removed by washing the wells three times with 250 1A of TBS-T. One hundred microliters of R183 antiserurn diluted 1:3,000 in PBS was added, and the plates were incubated at 37'C for I h, followed by three washes with TBS-T. One hundred microliters of AP-conjugated goat antirabbit IgG (Zymed Laboratories) diluted 1: 1,000 in PBS was added, and the plates were incubated at 37'C for I h, followed by three washes with 250 Vd of TBS-T Bound AP-conjugated goat anti-rabbit antibodies were detected as described above.
Confocal microscopy and image analysis. Slides with tissue sections were treated with xyline and dehydrated with 95% A reversal of binding assay was used to quantitatively measure the reversal of rNoVLP binding to HBGA in BSDT The assay was similar to the rNoVLP binding assay except an additional incubation step was added before the R183 primary antibody was applied. Briefly, after rNoVLP binding to the BSDTcoated plate, the plate was washed three times with PBS and incubated with PBS, PBS containing variable concentrations of PGM (ranging from 0.01 to l'/r), or PBS containing 1% sucrose at room temperature for I h, with exchange of incubation buffer every 20 min. Then, R183 antiserUm, AP-conjU gated goat antirabbit IgG was added, and bound AP-conjugated goat anti-rabbit antibodies were detected as described above. The OD reading of PBS-treated samples was designated as 100% binding.
Results and statistical analyses. The cut-off point for ELISA was calculated by positive-to-negative (P/N) ratios (7).
Negative controls included blank control wells that contained all reagents except oyster homogenate and control wells coated with oyster homogenate but absent primary MAbs. The greater OD reading from the two controls was used to calculate P/N ratio.
Samples were considered positive when the P/N ratio was -2 '
The inhibition of rNoVLP binding was determined by calculating the OD readings from treated groups relative to the PBS-treated control group. The OD from the PBS control group was calculated as 100%. Data comparisons between more than two groups were determined by a one-way analysis of variance (ANOVA) and the Holm-Sidak post hoc test. Correlations and associated P values were determined by Spearman rank-order correlation. All samples analyzed included at least triplicates and represented at least two vir^qinica oysters, clams, and mussels. Binding activity was decreased significantly by 0) oxidation of BSDT by potassium periodate, (ii) dose-dependent blocking of type A H13GA with a specific MAb, or (iii) dose-dependent competition by addition of free Hl3GA (Fig. 2) . The binding of rNoVLP to oxidized BSDT was decreased 67% (P < 0.02) compared with untreated BSDT The binding of rNoVLP to (Fig. 313) , clams (Fig. 3E ), and mussels (Fig. 3H) .
(fl\ I I , 1 1 -'d I'lot, \,,I _^J . V, 1) Ifl\I)1\G ()[ I 'll ( ()\111)1\ \\ I \()I,()\ ll\,l " I () (^ \, I I\ il\\l (111', I\ HI\ \1\1"
Localization of rNoVLP binding was observed in a similar
pattern to the A Hl3GA (Fig. 3A, 3D , and 3G). Overlapping binding of antibodies against rNoVLP (R 183) and type A H13GA (MAb BG2) indicated co-localization of rNoVLP binding and type A expression within epithelial cells lining the lumen of BSDT (Fig. 3C, 3F, and 31) . When type 0-specific MAb was used, different patterns were observed ( Fig. 3J through 3L) . rNoVLP bound to regions of the epithelia] cell tissue (intense green in Fig. 3J) ; however, the binding of type 0 MAb was observed in different locations and patterns (Fig. 3K) . Co-localization of type 0 H13GA and rNoVLP binding was not observed when signals were overlapped. The green and red staining remained green and red in these different locations (Fig. 31) . To rule out the possibility of the nonspecific binding of fluorescence-conJugated NlAbs to BSDT slides, slides were incubated with a type B-specific MA and MAbs conjugated to Alexa 488 and Alexa 568, followed by counterstaining with Syto 62 (pseudoblue). Syto 62 DNA counterstain was used to show general tissue structure (Fig. 3M) .
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-1 14-) (Fig. 31 and  3J) , although type O-like H13GA was also present ( gested by a human will usually be exposed to saliva before they contact the receptors on gastrointestinal cells, the role 
